Charles River (CRL) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Weekly Buzz: Last Short Week of Jan Sees Records, Trump Gives Orders
Kevin Travers16:12 ET
Wall Street Today: Market Pulls Back After Wild Week
Kevin Travers16:04 ET
Live Stock: First Week Down, Market Pulls Back a Hair After Records
Kevin Travers11:12 ET
Wall Street Today: S&P 500 Closes at Record, Trump Keeps Appearing on TV
Kevin TraversJan 23 16:07 ET
What Analysts Are Saying About Charles River Stock
BenzingaJan 23 14:00 ET
Life Sciences Stocks Fall on NIH Funding Concerns
Seeking AlphaJan 23 12:55 ET

Comments

韭菜变主力

Jan 17 22:05

$Charles River (CRL.US)$ It’s cheap, but no sizable upside without material improvement of the earnings. 140s might be in the cards. Go against the trend is a dangerous thing. Those sitting on a loss have to cut loss given the extreme resistance above. Only improvement of the earnings can save this stock. They also seem to be losing some clients to competitors.

韭菜变主力

Dec 30, 2024 01:18

$Charles River (CRL.US)$ In this almost everything rally market with stocks doubling easily, biomedical research companies have found growth is extremely hard to come by, and P/E has been stuck going nowhere.

Moomoo AI

Feb 29, 2024 01:09

The CEOs of both Wheeler Bio and Charles River express optimism about the partnership, believing that the integration of discovery CRO and CDMO workflows will speed up the path to first-in-human trials and bring new treatments to patients faster.

Press Release: Wheeler Bio Seals Agreement With Charles River to Offer Portable CMC(R) to Discovery Clients to Accelerate Their Journey to First-in-Human Use

Moomoo AI

Feb 26, 2024 04:44

Insider's recent share sale, even below current price, suggests satisfaction with lower valuation. Despite high insider ownership, this selling hints at caution. The company also has 1 warning sign worth noting before buying shares.

Have Charles River Laboratories International Insiders Been Selling Stock?

Moomoo AI

Feb 16, 2024 09:18

EPS growth outshines the yearly share price gain of 12%, indicating market caution towards the stock. Despite sell-off, long term shareholders gained 12% annually over five years, suggesting the sell-off might be a growth opportunity.

Charles River Laboratories International (NYSE:CRL) Stock Performs Better Than Its Underlying Earnings Growth Over Last Five Years

1

CRL Charles River

Trade Overview

Capital Trend

News

Comments